Editor in Chief, Commercial Insights, Citeline - Scrip, In Vivo, Generics Bulletin - covering biopharma news and analysis. All views are my own.
London
Joined July 2011
- Tweets2.9K
- Following954
- Followers2.2K
- Likes72
Eleanor Malone retweeted
heading to the Senate this afternoon for the Bernie-Insulin makers-PBM showdown.
More Wednesday reading ... #pinksheet #pharma: Even As PBMs Face Reckoning, Formulary Exclusions Rise Again In 2023 pink.pharmaintelligence.info…
A group of us @citeline and @norstella are taking part in #RaceforLife in memory of our colleague Maureen Kenny - @scripregmaureen - and we would love to raise as much as possible for cancer research... fundraise.cancerresearchuk.o…
My brilliant, funny, lovely dad.
Andrew Malone obituary theguardian.com/society/2023…
We're hiring! We need a US reporter with experience covering #biopharma to join our global team of expert journalists at @PharmaScrip. If you can bring expert analysis to industry events and trends, apply here: linkedin.com/jobs/view/33029…
Eleanor Malone retweeted
Are you our new Features Writer?
Know someone who might be?
Find our latest available role and apply now: bit.ly/3J4KNbn
#recruuiting #writer #jobsearch #jobs
We're hiring! Do you know about US drug pricing, reimbursement and #pharma market #strategy? We're looking for a new team member to provide regular updates and analysis for our pharma industry clients. Check out the details below jobs.smartrecruiters.com/Inf…
Journalists! We are looking for an enterprising investigative reporter to build a beat around drug pricing, reimbursement and market strategy for subscribers to @PharmaScrip's analytical news and insights service (part of the @pharma_intell suite)
jobs.smartrecruiters.com/Inf…
We are looking for a feature and interview writer to join @INVIVOnow as part of the @pharma_intell family jobs.smartrecruiters.com/Inf…
We're hiring on @PharmaScrip and @INVIVOnow for great journalists to dig deep into #pharma issues like drug pricing, business strategy and scientific innovation. Apply here: jobs.smartrecruiters.com/Inf… & jobs.smartrecruiters.com/Inf…
And a very warm welcome To Chloe - we're so excited you've joined @DaveGenerics and our @Genericbulletin team!
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Eleanor Malone retweeted
A very warm @PharmaScrip welcome to our new colleague @Ayisha_Sharma97! Great to have you on our team of biopharma journalists Ayisha. Here's her dive into base editing, a next-big-thing in gene editing.
scrip.pharmaintelligence.inf…
Eleanor Malone retweeted
@dgingery analyzes Califf's previous Senate confirmation history to preview what might happen now
Califf Confirmation Hearing Round Two: Industry Ties Once Again May Bark Loud, Bite Lightly pink.pharmaintelligence.info…
Are you an expert in US pharma pricing, reimbursement & markets? Can you write compelling news/analysis for pharma decision makers? We want to recruit a journalist to build a beat around commercial strategy, drug pricing and the payer environment for Scrip lnkd.in/erXaqQnr
There's still time to sign up for the @Pharma_Intell three-part panel discussion series on cell and gene therapies. First one starts in 90 mins, on novel development strategies for clinical trials pages.pharmaintelligence.inf…
Eleanor Malone retweeted
Lot of plain speaking here by NIH chief & Hamburg. WHO efforts/role valuable/critical but very difficult for it to be driver of big policy changes & it shouldn’t pretend to be a regulatory agency pink.pharmaintelligence.info…
Check out our new 2021 line-up of 30 rising leaders in pharma, biotech & health tech just published in @INVIVOnow invivo.pharmaintelligence.in… @Pharma_Intell
Join @INVIVOnow on May 18 for a panel discussion on leadership in times of uncertainty and upheaval, with Mark Reisenauer from @AstellasUS, Albireo's Ron Cooper, Semi Trotto from Thrive Earlier Detection and Catherine Owen, @bmsnews pages.pharmaintelligence.inf…
Eleanor Malone retweeted
The 2021 #PharmaRnDReview is coming soon! Did COVID-19 hold back R&D pipeline expansion? Not a bit of it - our data shows a further 4.8% rise in the number of drugs in development, to over 18.5K. #pharmaintelligence
Scrip Asks…What Does 2021 Hold For Biopharma? Part 5: Business Environment And Strategy scrip.pharmaintelligence.inf… FREE TO VIEW - the final part of our series, in which 200+ execs/experts shared with @PharmaScrip their predictions. Expect deals aplenty...
17 ways in which the pandemic has changed things for the biopharma sector: Free to view.
Scrip Asks…What Does 2021 Hold For Biopharma? Part 2: COVID-19 Shock Waves And Silver Linings scrip.pharmaintelligence.inf…